AVEO Pharmaceuticals, Inc.
(NASDAQ CM: AVEO)
Rigrodsky Law, P.A. is investigating AVEO Pharmaceuticals, Inc. (“AVEO”) regarding possible breaches of fiduciary duties and other violations of law related to AVEO’s agreement to be acquired by LG Chem, Ltd. Under the terms of the agreement, AVEO’s shareholders will receive $15.00 per share.